Sanne de Bruin

120 Chapter 4 References 1. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill - Current clinical practice in the United States. Crit Care Med . 2004;32(1):39-52. doi:10.1097/01. CCM.0000104112.34142.79 2. Vincent J-L, Jaschinski U, Wittebole X, et al. Worldwide audit of blood transfusion practice in critically ill patients. Crit Care . 2018;22(1):102. doi:10.1186/s13054-018-2018-9 3. Stanworth SJ,WalshTS, Prescott RJ, Lee RJ,Watson DM,Wyncoll DLA. Thrombocytopenia and platelet transfusion in UK critical care: Amulticenter observational study. Transfusion . 2013;53(5):1050-1058. doi:10.1111/j.1537-2995.2012.03866.x 4. Stanworth SJ, Walsh TS, Prescott RJ, et al. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care . 2011;15(2):R108. doi:10.1186/cc10129 5. Harvey AR, Basavaraju S V., Chung KW, Kuehnert MJ. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012. Transfusion . 2015;55(4):709-718. doi:10.1111/trf.12918 6. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med . 1999;340(6):409-417. doi:10.1056/ NEJM199902113400601 7. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med . 2011;365(26):2453-2462. doi:10.1056/NEJMoa1012452 8. Holst LB, Haase N, Wetterslev J, et al. Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock. N Engl J Med . 2014;371(15):1381-1391. doi:10.1056/NEJMoa1406617 9. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. J AmMed Assoc . 2002;288(12):1499-1507. http://www.ncbi.nlm.nih.gov/pubmed/12243637. 10. Carson JL, Brooks MM, Abbott JD, et al. Coronary artery disease liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J . 2013;165(6):964-971. e1. doi:10.1016/j.ahj.2013.03.001 11. Simon GI, Craswell A, ThomO, Fung YL. Outcomes of restrictive versus liberal transfusion strategies in older adults fromnine randomised controlled trials: a systematic review andmeta-analysis. Lancet Haematol . 2017;4(10):e465-e474. doi:10.1016/S2352-3026(17)30141-2 12. McIntyre L, Tinmouth AT, Fergusson DA. Blood component transfusion in critically ill patients. Curr Opin Crit Care . 2013;19(4):326-333. doi:10.1097/MCC.0b013e3283632e56 13. Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust . 2003;178(3):117-121. 14. Gajic O, Dzik WH, Toy P. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: Benefit or harm? Crit Care Med . 2006;34(5 SUPPL.). doi:10.1097/01. CCM.0000214288.88308.26 15. Görlinger K, Saner FH. Prophylactic plasma and platelet transfusion in the critically Ill patient: Just useless and expensive or even harmful? BMC Anesthesiol . 2015;15(1):1-5. doi:10.1186/s12871-015-0074- 0